Results 21 to 30 of about 38,436 (213)

A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update.

Journal of Clinical Endocrinology and Metabolism, 2020
OBJECTIVE The aim of the Acromegaly Consensus Group was to revise and update the consensus on diagnosis and treatment of acromegaly comorbidities last published in 2013.
A. Giustina, A. Barkan, A. Beckers, N. Biermasz, Beverly M. K. Biller, C. Boguszewski, M. Bolanowski, V. Bonert, M. Bronstein, F. Casanueva, D. Clemmons, A. Colao, D. Ferone, M. Fleseriu, S. Frara, Mônica R. Gadelha, E. Ghigo, M. Gurnell, A. Heaney, Ken K. Y. Ho, A. Ioachimescu, L. Katznelson, F. Keleştimur, J. Kopchick, M. Kršek, S. Lamberts, M. Losa, A. Luger, P. Maffei, M. Marazuela, G. Mazziotti, M. Mercado, P. Mortini, S. Neggers, Alberto M. Pereira, S. Petersenn, M. Puig-Domingo, R. Salvatori, I. Shimon, C. Strasburger, S. Tsagarakis, A. J. van der Lely, J. Wass, M. Zatelli, S. Melmed   +44 more
semanticscholar   +1 more source

A Pituitary Society update to acromegaly management guidelines

Pituitary, 2020
Guidelines and consensus statements ensure that physicians managing acromegaly patients have access to current information on evidence-based treatments to optimize outcomes.
M. Fleseriu, B. Biller, P. Freda, M. Gadelha, A. Giustina, L. Katznelson, M. Molitch, S. Samson, C. Strasburger, A. J. van der Lely, S. Melmed   +10 more
semanticscholar   +1 more source

The Biochemical Diagnosis of Acromegaly

Journal of Clinical Medicine, 2021
Background: The diagnosis of acromegaly still poses a clinical challenge, and prolonged diagnostic delay is common. The most important assays for the biochemical diagnosis and management of acromegaly are growth hormone (GH) and insulin-like growth ...
A. Akirov, H. Masri-Iraqi, I. Dotan, I. Shimon   +3 more
semanticscholar   +1 more source

Is H19 RNA a Useful Marker of Acromegaly and Its Complications? A Preliminary Study

Biomedicines, 2023
Acromegaly is a rare endocrine disorder caused by somatotroph pituitary adenoma. Besides its typical symptoms, it contributes to the development of cardiovascular, metabolic, and bone comorbidities. H19 RNA is a long non-coding RNA and it is suspected to
Małgorzata Rolla, Aleksandra Jawiarczyk-Przybyłowska, Katarzyna Kolačkov, Agnieszka Zembska, Marek Bolanowski   +4 more
doaj   +1 more source

Acromegaly without acral anomalies [PDF]

Romanian Journal of Medical Practice, 2021
Early recognition of a pituitary secretor tumor offers a better prognostic; thus acromegaly might be recognized before the actual clinical picture of acromegaly is detectable.
Mara Carsote, Florica Sandru, Diana Elena Rentea, Claudia Mehedintu, Stefania Zugravu, Corina Chirita, Mihai Cristian Dumitrascu   +6 more
doaj   +1 more source

A Consensus Statement on acromegaly therapeutic outcomes

Nature Reviews Endocrinology, 2018
The 11th Acromegaly Consensus Conference in April 2017 was convened to update recommendations on therapeutic outcomes for patients with acromegaly. Consensus guidelines on the medical management of acromegaly were last published in 2014; since then, new ...
S. Melmed, M. Bronstein, P. Chanson, A. Klibanski, F. Casanueva, J. Wass, C. Strasburger, A. Luger, D. Clemmons, A. Giustina   +9 more
semanticscholar   +1 more source

CONDITION OF THE MUSCULOSKELETAL SYSTEM IN PATIENTSWITH ACROMEGALY.

Остеопороз и остеопатии, 2010
Despite the relatively low incidence of acromegaly (60-70 cases per I million inhabitants), this disease has a special place among the heterogeneous group of diseases that lead to the defeat of the locomotor apparatus.
A S Fedotova, N N Molitvoslovova, L I Alekseeva, L Ya Rozhinskaya, A. S. Fedotova, N. N. Molitvoslovova, L. I. Alexeeva, L. Y. Rozhinskaya   +7 more
doaj   +1 more source

Acromegaly

Nature Reviews Disease Primers, 2019
Acromegaly is characterized by increased release of growth hormone and, consequently, insulin-like growth factor I (IGF1), most often by a pituitary adenoma. Prolonged exposure to excess hormone leads to progressive somatic disfigurement and a wide range
W. E. Holmes, Reajiei, Surgeey, Corclusioi   +3 more
semanticscholar   +2 more sources

Rheumatic manifestations of acromegaly [PDF]

Остеопороз и остеопатии, 2020
Acromegaly is a chronic endocrine disease characterized by excessive secretion of growth hormone (GH), which, in turn, leads to increased insulin-like growth factor 1 (IGF-1) secretion by the liver.
Taras S. Panevin, Lyudmila I. Alekseeva, Galina A. Melnichenko   +2 more
doaj   +1 more source

Heat Intolerance and Hyperhidrosis as the only Presenting Manifestations of Acromegaly: A Case Report [PDF]

Journal of Clinical and Diagnostic Research, 2020
Acromegaly is a state of Growth Hormone (GH) excess characterised by coarse facial features, acral enlargement, hyperhidrosis, headache, visual disturbances and visceromegaly. The most common cause of acromegaly is pituitary adenoma.
TN Kamalesh, HA VIJAYA SARATHY, NT SREEDEVI   +2 more
doaj   +1 more source